Tarsadia Investments
520 Newport Center Drive, 21st Floor, Newport Beach, CA, 92660, United States
Overview
Tarsadia Investments is a private investment firm. They focus on providing capital and strategic support for companies with substantial growth potential. The firm seeks to invest in healthcare, financial services, real estate, life science, clean technology, and alternative investment sectors.
- Total investments
- 11
- Lead investments
- 6
- Investments · 12mo
- 0
- Active investors
- 3
Sector focus
- Business Development
- Finance
- Financial Services
- Venture Capital
Investment portfolio
- Yieldstreet
Led · Series D · Jun 2025
Yieldstreet operates a technology-driven private markets investment platform offering access to alternative assets across ten asset classes, including real estate, private credit, private equity, and art. The company reports having over 500,000 members using its platform. Yieldstreet closed an initial $45 million equity investment as part of a planned $60 million Series D to fund growth and continue delivering private market alternatives. Management says the new capital will be used to accelerate growth plans and enhance the company’s technological infrastructure. Investors and partners highlighted Yieldstreet’s distribution and platform capabilities as core strengths. The financing is described as strengthening Yieldstreet’s financial footing as it expands private markets opportunities for investors. Yieldstreet operates an online marketplace that lets eligible retail investors access private-market alternatives such as real estate, private credit, private equity, art and other asset classes. The company creates funds and products with lower minimums to widen access to investment strategies that were previously mostly available to institutions and ultra-wealthy individuals. Yieldstreet emphasizes partnerships with asset managers, sponsors, and originators to source diversified opportunities across litigation finance, small business, consumer, private funds and real estate. Founded in 2015 and headquartered in New York City, Yieldstreet has attracted more than 400,000 users and over $3 billion in funding on its platform to date. The company positions itself to scale its product suite and increase the number and scope of offerings for its investor base. Management says additional capital and financing capacity will accelerate deal flow and platform growth. Yieldstreet is a multi-asset alternative investment platform that gives retail investors access to alternative investments previously reserved for institutions and ultra-high-net-worth individuals. Its technology platform offers products across asset classes including Real Estate, Commercial, Consumer, Art, Marine, Legal Finance and Aviation. Since its foundation in 2015, Yieldstreet has funded over $2.5 billion of investments and has over 325,000 members on its platform. The company is headquartered in New York City and has offices in Brazil, Greece and Malta. Yieldstreet plans to use new capital to advance its technology roadmap, expand sales and marketing capabilities, and grow its international distribution. Its stated mission is to help millions generate $3 billion of income outside the traditional public markets by 2025, and it is backed by venture capital firms, large family offices and private equity investors. Yieldstreet operates an online marketplace that fractionalizes institutional-style, asset-backed investments (real estate, art, marine/shipping, legal finance, commercial loans) for retail investors. The company has funded nearly $1.9 billion on its platform and reports about 300,000 consumers signed up, up from roughly 100,000 in February 2019. Since inception it says it has provided nearly more than $950 million in principal and interest payments to investors. Yieldstreet expects over 50% revenue growth in the current year versus 2020. The firm plans to use new capital to expand its user base, develop new investment products, pursue strategic acquisitions and explore international expansion into Europe and Asia. Yieldstreet was co‑founded by Milind Mehere and Michael Weisz and maintains headquarters in New York City with offices in Brazil, Greece and Malta. YieldStreet operates an online platform that offers access to alternative investments across asset classes including real estate, marine/shipping, legal finance and commercial loans. The company has attracted more than $600 million invested on its platform from over 100,000 members, with an expected 12% IRR and more than $300 million in principal and interest paid to investors. Until now the platform has required users to be accredited investors; YieldStreet also offers YieldStreet Wallet, a savings product paying 2.2% interest that is open to everyone. The new capital will be used to expand the platform and create investment vehicles that do not require accredited status, and the company is working through the legal and regulatory aspects of those products. Management is also exploring ways to enable retirement and IRA account access for users. YieldStreet operates in the U.S. and positions itself as a democratising force to broaden access to products previously reserved for institutions.
- Fathom
Participated · Series B · Nov 2022
Fathom builds an autonomous medical coding platform that combines deep learning and natural language processing to enable health systems to deploy autonomous coding with automation across departments. The company states this implementation model delivers ROI with immediate operating margin impact. Led by CEO Andrew Lockhart and based in San Francisco, Fathom received a strategic investment from CVS Health Ventures. The company plans to use the funds to expand operations and accelerate development efforts. The article did not disclose revenue, user metrics, prior funding rounds, or valuation.
- Chronus Health
Led · Series A · Jan 2022
Chronus Health is a point-of-care diagnostics company developing a portable in-vitro diagnostics (IVD) platform to deliver real-time blood diagnostics at the point of care. The system is designed to provide lab results in minutes and to handle approximately 85% of the blood tests performed annually. Chronus leverages microfluidic and semiconductor technologies to create a compact, low-cost alternative to bulky, expensive central-lab analyzers. The company positions its platform to improve time-to-care and patient outcomes and to disrupt the clinical lab testing market. Chronus is a Fogarty Innovation company based in Mountain View, Calif. It intends to use new financing proceeds to scale research, engineering, and data-science teams and to accelerate product and technology development.
- Petal
Led · Series D · Jan 2022
Petal issues Visa credit cards (issued by WebBank) that let consumers who are new-to-credit qualify using their banking history rather than established credit scores. The company enables individuals to build credit histories and targets millions of U.S. consumers with limited or no traditional credit data. Petal has approved nearly 400,000 consumers for its credit cards to date, including more than 100,000 new cards approved in 2022. Led by CEO and co-founder Jason Rosen, the company plans to expand the Petal credit card program using the new capital. With the announced transactions Petal has raised more than $300M in equity capital and more than $680M in debt financing to date. The firm is based in New York, NY and Richmond, VA. Petal issues three Visa credit card products and a companion mobile app that use cash-flow underwriting (and traditional credit scores when available) to help underserved consumers build credit. Its cards are issued by WebBank while Petal manages servicing and monetizes via interchange, interest and card fees (including a $59 Rise membership). Demand has grown rapidly: Petal added 100,000 cardholders last year and reported 300,000 cardholders at its January 2022 Series D. At that time it said it was doing $20–30 million in annualized revenue, which rose to $80 million by year-end; management projects profitability sometime in 2024. The company says delinquency and default rates have not risen and have been improving this year. Petal conducted a restructuring in Q3 that reduced headcount by about 10% and currently has roughly 140 employees. Petal is spinning out its Prism Data unit (established in 2021, ~10 employees) to commercialize its cash-flow underwriting technology to other lenders and fintechs. Founded in 2016 and based in New York, Petal offers two Visa credit card products and a mobile app designed to help consumers build credit responsibly by underwriting on cash flow rather than traditional credit scores. Its proprietary underwriting, branded CashScoring, analyzes banking history—income, spending and savings—and was productized into Prism Data, a B2B platform launched in 2021 to provide transactional scoring and insights to other fintechs and financial institutions. Over the past year Petal tripled its user base and more than quadrupled revenue, growing from $11 million to nearly $50 million; it now reports nearly 300,000 cardholders and adds 10,000–20,000 new members per month. The company says members who joined with no prior credit history have reached an average credit score of 676. Petal has more than 160 employees (doubling over the last year) and plans to hire 100+ roles in 2022 while adding new card features and scaling to hundreds of thousands more cardmembers. Prism Data is described as a sister company and a strategic growth channel alongside Petal’s consumer card business. Petal is a New York, NY and Richmond, VA-based credit-card company that issues two Visa cards, Petal 1 and Petal 2. Petal 1 targets consumers with existing credit history; Petal 2 helps people build credit with a no-fee card, cash back and higher limits for those new to credit. The company uses a Cash Score—an alternative measure based on income, savings, and spending history—to evaluate creditworthiness and encourage responsible spending. Petal credit cards are issued by WebBank, Member FDIC. To date more than 100,000 people have been approved for the two cards. The company intends to use new financing to expand and support the Petal credit card program. Petal issues consumer credit cards and distinguishes itself by underwriting applicants based on prospective cash flow rather than traditional credit scores, enabling access for underbanked users. The company has grown by “tens of thousands” of customers since early 2019 and now employs about 100 people while operating remotely. Petal opened a second office in Richmond, Virginia and recently hired Kaustav Das as chief risk officer, bringing experience from Kabbage. Financially, Petal has raised equity rounds totaling roughly $100 million and in September secured a $300 million debt facility from Jeffries to finance its card product. In April the company closed a $55 million Series C to support expansion. Management’s near-term goal is to onboard hundreds of thousands of new customers over the next two years.
- AvantStay
Led · Series B · Dec 2021
AvantStay operates a technology-enabled short-term rental platform focused on group travel and premium, design-forward vacation homes. The company manages over 1,000 properties in 100 cities and reports more than $2 billion in assets under management. Its offering combines hospitality, design, and real-estate services to deliver turnkey stays while generating higher yields for property investors. AvantStay intends to use fresh capital to expand its portfolio and enter additional markets, further institutionalizing short-term rentals as an investable asset class. In December, the company announced a Series B round backed by Tarsadia Investments, 3L Capital, and Saluda Grade. The latest raise deepens AvantStay’s partnership with real-estate advisory firm Saluda Grade, positioning the startup to accelerate growth and broaden its footprint in the burgeoning STR sector.